Richard A. Heyman sold $4K of ORIC stock

Richard A. Heyman, Dir of Oric Pharmaceuticals, Inc. (ORIC), sold 300 shares of ORIC stock worth $4K, per an SEC Form 4 filed Jul 8, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 6, 2026, 2 days before it was made public.

ORIC has moved -19.2% since the trade date, from $10.91 to $8.82 (Nov 6, 2026 close).